Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone ResistancePatrick N. A. Harris, David L. Paterson, Nick Daneman et al.|JAMA|2018Cited by 761
Metagenome-wide association analysis identifies microbial determinants of post-antibiotic ecological recovery in the gutKern Rei Chng, Niranjan Nagarajan, Tarini Shankar Ghosh et al.|Nature Ecology & Evolution|2020Cited by 178
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO StudyAndrew Henderson, Bassam Alalwan, David L. Paterson et al.|Clinical Infectious Diseases|2020Cited by 155
Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing EnterobacteriaceaeTat Ming Ng, David Chien Lye, Wendy Xiao Ling Khong et al.|PLoS ONE|2016Cited by 128
Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysisDanielle K. Longmore, Plataki, Jessica E. Miller et al.|Diabetes Care|2021Cited by 101